MARKET

RVPHW

RVPHW

Reviva Pharmaceutcls Hldgs Inc
NASDAQ
0.0089
-0.0008
-8.25%
Opening 11:21 12/05 EST
OPEN
0.0073
PREV CLOSE
0.0097
HIGH
0.0096
LOW
0.0073
VOLUME
41.78K
TURNOVER
--
52 WEEK HIGH
0.7800
52 WEEK LOW
0.0050
MARKET CAP
--
P/E (TTM)
-0.0188
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RVPHW last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at RVPHW last week (1117-1121)?
Weekly Report · 11/24 10:23
Weekly Report: what happened at RVPHW last week (1110-1114)?
Weekly Report · 11/17 10:23
Reviva Pharmaceuticals Q3 net loss narrows
Reuters · 11/13 21:21
BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.06
Reuters · 11/13 21:05
Reviva Pharmaceuticals Granted European Patent for Brilaroxazine in Pulmonary Fibrosis Treatment
Reuters · 11/10 13:06
REVIVA ANNOUNCES GRANT OF EUROPEAN PATENT COVERING USE OF BRILAROXAZINE FOR THE TREATMENT OF PULMONARY FIBROSIS
Reuters · 11/10 13:00
Weekly Report: what happened at RVPHW last week (1103-1107)?
Weekly Report · 11/10 10:21
More
About RVPHW
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Webull offers Reviva Pharmaceuticals Holdings, Inc. stock information, including NASDAQ: RVPHW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPHW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPHW stock methods without spending real money on the virtual paper trading platform.